Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bezafibrate[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[7] 20, 93, 94, 160, 296, 316, 324 💬
2Bezafibrate (drug)[1] Bezafibrate[1] Bezafibrate 💬 [1] PPARA 💬 [10] Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬[1] 316 💬
3Break in L-carnitine treatment[1] Levocarnitine[1] Levocarnitine 💬 --[1] 316 💬
4Carnitine[1] Levocarnitine[1] Levocarnitine 💬 --[9] 5, 13, 58, 86, 96, 97, 265, 298, 316 💬
5Glycerol[1] Glycerin[1] Glycerin 💬 --[5] 6, 13, 79, 316, 317 💬
6Glycerol/Saline[1] Glycerin[1] Glycerin 💬 --[2] 316, 317 💬
7Heparin[1] Heparin[1] Adomiparin 💬 [1] SERPINC1 💬 [1] Complement and coagulation cascades 💬[11] 47, 60, 70, 84, 107, 224, 226, 280, 299, 316, 317 💬
8Hyperinsulinemic euglycemic clamp----[2] 316, 317 💬
9Intralipid/Heparin[1] Heparin[1] Adomiparin 💬 [1] SERPINC1 💬 [1] Complement and coagulation cascades 💬[2] 316, 317 💬
10L-Carnitine[1] Levocarnitine[1] Levocarnitine 💬 --[7] 13, 86, 96, 97, 265, 298, 316 💬